Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E K Van Obberghen

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
The Journal of Headache and Pain|April 9, 2025
Cluster headache diagnostic delay and its predictors: a systematic review with a meta-analysisE K Van Obberghen, R Fabre, M Lanteri-Minet
The Journal of Headache and Pain|December 4, 2025
Cluster headache suicidality: a systematic review with a meta-analysisE K Van Obberghen, R Fabre, M Lanteri-Minet
Revue Neurologique|April 5, 2017
Multiple immune disorders after natalizumab discontinuation: After the CIRIS, the SIRIS?E K Van Obberghen, M Cohen, F Rocher, et al.
Revue Neurologique|December 17, 2025
Trends in the real-world management of cluster headache patients treated by subcutaneous sumatriptan and/or oxygen in France - An analysis of the French National Social Security System Open Data over eleven years (2014-2024)E K Van Obberghen, R Fabre, L Bailly, et al.
The Journal of Headache and Pain|November 8, 2023
One-year prospective real-world assessment of effectiveness and safety of erenumab in migraine prevention: results of the French FHU INOVPAIN registry studyM Lanteri-Minet, R Fabre, C Martin, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
The Journal of Headache and Pain|April 9, 2025
Cluster headache diagnostic delay and its predictors: a systematic review with a meta-analysisE K Van Obberghen, R Fabre, M Lanteri-Minet
The Journal of Headache and Pain|December 4, 2025
Cluster headache suicidality: a systematic review with a meta-analysisE K Van Obberghen, R Fabre, M Lanteri-Minet
Revue Neurologique|April 5, 2017
Multiple immune disorders after natalizumab discontinuation: After the CIRIS, the SIRIS?E K Van Obberghen, M Cohen, F Rocher, et al.
Revue Neurologique|December 17, 2025
Trends in the real-world management of cluster headache patients treated by subcutaneous sumatriptan and/or oxygen in France - An analysis of the French National Social Security System Open Data over eleven years (2014-2024)E K Van Obberghen, R Fabre, L Bailly, et al.
The Journal of Headache and Pain|November 8, 2023
One-year prospective real-world assessment of effectiveness and safety of erenumab in migraine prevention: results of the French FHU INOVPAIN registry studyM Lanteri-Minet, R Fabre, C Martin, et al.
Pageof 1